Print Page | Contact Us | Report Abuse | Sign In | Join SAPAA
Webinar: 2018 U.S. DOT Rule Changes: How Will They Impact You?
Register Tell a Friend About This EventTell a Friend
Webinar:  2018 U.S. DOT Rule Changes:  How Will They Impact You?

Join us for one of our monthly webinars.

 Export to Your Calendar 2/21/2018
When: Wednesday, February 21, 2018
2:00 PM
Where: United States
Contact: Anne Kelly, CAE, CMP
1-800-672-7229


Online registration is available until: 2/21/2018
« Go to Upcoming Event List  

WEBINAR:  2018 U.S. DOT Rule Changes:  How Will They Impact You? 

The drug testing industry is evolving, and many employers have used U.S. Department of Transportation standards as their model for non-federally mandated employee testing.  In 1991, Congress passed the Omnibus Transportation Employee Testing Act (OTETA) which, in part, required the Department and DOT agencies to look to the Department of Health and Human Services (HHS) for the scientific and technical guidelines regarding the drugs for which we test and specimens we collect.  HHS rules have now changed affecting DOT; now the question is how has it affected you?

 

This webinar will break down what critical items have changed from U.S. DOT that impact employers, laboratories, C/TPA’s, medical review officers, collectors, and breath alcohol technicians, which modes have recent modifications to their rules, and provide guidance going forward to implement these changes successfully.


 

Jeff Sims is the President of a’TEST Consultants, Inc., a nationally recognized drug testing corporation since 1992, and a lifetime member of the Substance Abuse Program Administrators Association.  He is actively involved in new business development, volunteer public speaking, and is an author of several training courses used by his industry. 

Jeff began his drug-testing career in 1987 at the University of Arkansas for Medical Sciences (U.A.M.S.), while he was in college at the University of Arkansas at Little Rock.  He is Arkansas’ only Certified Substance Abuse Program Administrator, is currently serving a fourth term on the Board of SAPAA, is a past President of SAPAA, past Legislative Affairs Chairperson of SAPAA, a member of the Drug and Alcohol Testing Industry Association, and is serving as a Commissioner for The Certification Commission for Drug and Alcohol Program Professionals. 

Jeff’s other notable accomplishments include a series of student drug testing presentations for the White House Office of National Drug Control Policy throughout the country, testifying as an industry expert during oversight hearings in the U.S. House of Representatives, being one of only seventeen awarded the U.S. Small Business Administration’s Paul D. Coverdale Drug-free Workplace Grant, and being recruited as an independent policy expert to audit and help redevelop the drug-free workplace of the Pacific Northwest National Laboratory post recreational marijuana legalization.